Today

Agents

Chat

Arena

Discover

More

App

Syndax Pharmaceuticals Q2 Operating Income USD -39.995 Million - SNDX News | Rallies

Syndax Pharmaceuticals Q2 Operating Income USD -39.995 Million

SNDX•2026-08-04

Quarterly results

Aug. 4 (Reuters) - Syndax Pharmaceuticals Q2 operating expenses were USD 112.783 million.

Q2 net income was USD -49.363 million vs. IBES estimate USD -39.4 million
Q2 cash & investments were USD 575.1 million

Related News

MEC Q2 net loss widens to $2.1 million; net sales rise 23.2% year over year to $163 million

MEC•2026-08-04

CompX declares regular quarterly dividend of $0.3 a share

CIX•2026-08-04

CompX Q2 FY26 net income rises 30.91% to $7.2 million; net sales increase 8.19% to $43.6 million

CIX

•

2026-08-04

Kodak swings to GAAP profit of $17 million in Q2 FY26; revenue rises 18% to $311 million

KODK•2026-08-04

Kodak outlines growth principles, capital allocation framework in investor presentation

KODK•2026-08-04